The global branched stent grafts market is witnessing significant growth due to the increasing prevalence of aortic aneurysms and the growing adoption of minimally invasive vascular procedures. Branched stent grafts are advanced medical devices used in endovascular aneurysm repair procedures to treat complex aneurysms involving branch arteries while maintaining blood flow to critical organs. These devices are increasingly preferred because they reduce surgical risks, shorten hospital stays, and improve patient recovery outcomes.

The global branched stent grafts market size was valued at USD 349.38 million in 2024 and is expected to grow from USD 376.28 million in 2025 to reach USD 681.15 million in 2033, growing at a CAGR of 7.7% during the forecast period (2025–2033). The increasing demand for minimally invasive cardiovascular procedures and advancements in vascular treatment technologies are major factors driving market growth.

Market Drivers

One of the major drivers of the branched stent grafts market is the increasing incidence of aortic aneurysms and other vascular disorders worldwide. Aging populations, hypertension, smoking, obesity, and changing lifestyles are contributing to rising cases of vascular diseases, increasing the demand for advanced treatment solutions.

Another important factor supporting market growth is the growing preference for minimally invasive surgical procedures. Compared to open surgical repair, branched stent graft procedures offer several benefits including lower surgical trauma, reduced blood loss, shorter hospital stays, and faster recovery periods. These advantages are encouraging healthcare providers and patients to adopt endovascular treatment methods.

Technological advancements in stent graft design are also contributing significantly to market expansion. Manufacturers are developing advanced branched and fenestrated stent graft systems with improved flexibility, enhanced durability, and greater anatomical compatibility. These innovations allow physicians to treat more complex vascular conditions with improved procedural success rates.

The increasing availability of advanced imaging technologies and improved surgical planning tools is further supporting market growth. Modern imaging systems help physicians accurately diagnose aneurysms and improve placement precision during endovascular procedures, enhancing treatment outcomes.

Rising healthcare expenditure and growing investments in cardiovascular care infrastructure are also creating additional growth opportunities. Hospitals and specialized vascular centers are increasingly adopting advanced treatment technologies to improve patient outcomes and reduce procedure-related complications.

Market Challenges

Despite strong growth opportunities, the branched stent grafts market faces several challenges. One of the major restraints is the high cost associated with branched stent graft procedures and advanced vascular devices. These procedures often require specialized equipment, trained professionals, and advanced imaging technologies, increasing treatment expenses.

Another challenge is the technical complexity involved in performing branched stent graft procedures. Successful implantation requires highly skilled vascular surgeons and extensive procedural expertise, which may limit adoption in healthcare facilities with limited specialization.

Strict regulatory approval processes for cardiovascular devices can also affect market growth. Manufacturers must meet rigorous safety and clinical performance requirements before introducing new products into the market, increasing development timelines and costs.

The market also faces challenges related to patient eligibility and anatomical limitations. Certain patients may not qualify for branched stent graft procedures due to complex vascular anatomy or associated medical conditions.

In addition, post-procedure monitoring and long-term device performance remain important considerations for healthcare providers and patients to ensure successful treatment outcomes.

Market Segmentation

The branched stent grafts market is segmented based on product type, application, end-user, and region.

By product type, the market includes thoracoabdominal branched stent grafts, abdominal branched stent grafts, and other specialized graft systems. Thoracoabdominal branched stent grafts hold a significant market share due to increasing treatment demand for complex aneurysm cases.

Based on application, the market is categorized into abdominal aortic aneurysm, thoracic aortic aneurysm, and others. The abdominal aortic aneurysm segment represents a major market share because of the growing prevalence of abdominal vascular disorders globally.

By end-user, the market includes hospitals, specialty clinics, ambulatory surgical centers, and others. Hospitals dominate the market due to the availability of advanced infrastructure, skilled healthcare professionals, and specialized vascular treatment facilities.

Regional Insights

North America holds a significant share of the global branched stent grafts market due to advanced healthcare infrastructure, increasing adoption of minimally invasive procedures, and rising prevalence of cardiovascular diseases. Strong investments in medical technology and specialized vascular treatment centers are supporting regional growth.

Europe represents another major market because of increasing awareness regarding advanced vascular therapies and growing healthcare expenditure. The region benefits from strong clinical research activities and widespread adoption of innovative endovascular procedures.

Asia-Pacific is expected to witness the fastest growth during the forecast period. Countries such as China, India, Japan, and South Korea are experiencing increasing rates of cardiovascular diseases and expanding access to advanced healthcare services. Improving hospital infrastructure and rising healthcare investments are supporting regional market expansion.

Latin America and the Middle East & Africa are emerging markets with improving healthcare facilities, increasing awareness regarding vascular disease treatment, and growing adoption of advanced medical technologies creating new growth opportunities.

Key Players Analysis

The branched stent grafts market is highly competitive, with major companies focusing on product innovation, research and development, strategic collaborations, and expansion activities to strengthen their market position. Key players operating in the market include Cook Medical, Medtronic plc, W. L. Gore & Associates, Inc., Endologix LLC, Bentley Innomed GmbH, and Cardinal Health Inc. These companies are continuously investing in advanced stent graft technologies and minimally invasive treatment solutions to improve procedural outcomes and expand their global presence.

For detailed insights, visit:
https://straitsresearch.com/report/branched-stent-grafts-market

About Us

Straits Research is a leading market research and intelligence organization specializing in research, analytics, and advisory services. The company provides comprehensive market reports, business intelligence, and industry analysis across multiple sectors to help businesses make informed strategic decisions and identify future growth opportunities.

Contact Us

Email: sales@straitsresearch.com
U.S. Tel: +1 646 905 0080
U.K. Tel: +44 203 695 0070